Camylofin + Paracetamol Syrup Franchise in Ahmedabad

Muscle Pain Relief Syrup Supplier in Mumbai

Analgesic & Muscle Relaxant Distributor in Delhi

Musculoskeletal Care Pharma Franchise in Bangalore

Camylofin Paracetamol Syrup Stockist in Hyderabad
Pain & Fever Care Syrup Manufacturer & Exporter in Chandigarh

Home/Products /camylofin-12-5mg-5ml-paracetamol-125mg-5ml-syrup

Camyfine P Syrup

Composition : Camylofin (12.5mg/5ml) + Paracetamol (125mg/5ml) Syrup

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 60ml

Price : ₹1/-

Camyfine P Syrup contains Camylofin 12.5mg/5ml + Paracetamol 125mg/5ml, a dual-action syrup for effective relief of muscle pain, spasms, and fever-related discomfort. Camylofin relaxes skeletal muscles, while Paracetamol provides fast-acting analgesic and antipyretic effects, offering comprehensive symptom control.

This syrup is widely prescribed for musculoskeletal pain, strains, and minor febrile conditions, providing patients with quick relief and improved comfort, which enhances adherence to therapy.

For franchise partners, Camyfine P Syrup represents a high-demand product in the pain and muscle care segment, offering strong repeat sales and market trust. Its dual-action formulation makes it a profitable addition to specialty portfolios, helping partners boost sales and strengthen market presence.

With rising incidences of muscle pain and fever-related discomfort, Camyfine P Syrup offers sustainable business opportunities, ensuring partners can capitalize on growing demand in musculoskeletal and analgesic care.

Read More

About the Product

Camyfine P Syrup contains Camylofin 12.5mg/5ml + Paracetamol 125mg/5ml, a dual-action syrup for effective relief of muscle pain, spasms, and fever-related discomfort. Camylofin relaxes skeletal muscles, while Paracetamol provides fast-acting analgesic and antipyretic effects, offering comprehensive symptom control.

This syrup is widely prescribed for musculoskeletal pain, strains, and minor febrile conditions, providing patients with quick relief and improved comfort, which enhances adherence to therapy.

For franchise partners, Camyfine P Syrup represents a high-demand product in the pain and muscle care segment, offering strong repeat sales and market trust. Its dual-action formulation makes it a profitable addition to specialty portfolios, helping partners boost sales and strengthen market presence.

With rising incidences of muscle pain and fever-related discomfort, Camyfine P Syrup offers sustainable business opportunities, ensuring partners can capitalize on growing demand in musculoskeletal and analgesic care.

Camyfine P Syrup is indicated for the relief of abdominal cramps, spasmodic pain, dysmenorrhea, and associated fever. It helps in conditions such as gastrointestinal colic, irritable bowel syndrome, and other functional bowel disorders where pain and muscle spasm are present.

Camyfine P Syrup is indicated for the relief of abdominal cramps, spasmodic pain, dysmenorrhea, and associated fever. It helps in conditions such as gastrointestinal colic, irritable bowel syndrome, and other functional bowel disorders where pain and muscle spasm are present.

Camyfine P Syrup should be taken strictly as prescribed. Avoid using multiple Paracetamol-containing products simultaneously to prevent overdose. Patients with liver disease, kidney impairment, or hypersensitivity to any component should consult a doctor before use.

Store Camyfine P Syrup in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date printed on the bottle.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation